Find More Contacts for Repligen
Protected Content
Chief HR Officer, HR Officer
Executive Human Resources
1 email found 1 phone number found
View contacts for Repligen to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email investors@repligen.com
  • Phone Number +1 781-250-0111

Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands,

a critical component of Protein A resins that are used to separate and purify monoclonal antibody therapeutics. Our ATF (Alternating Tangential Flow) systems and our growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market an innovative line of “ready-to-use” chromatography columns under our OPUS® and MediaScout® brands that we deliver pre-packed with our customers’ choice of resin. Repligen’s corporate headquarters are in Waltham, MA (USA) and our manufacturing facilities are located in Waltham, MA, Lund, Sweden and Weingarten, Germany.

Lists Featuring This Company

Consumer Goods Public Companies With More Than 500 Employees
390 Number of Organizations • $48.3B Total Funding Amount • 303 Number of Investors
Analytics Public Companies
224 Number of Organizations • $28.6B Total Funding Amount • 724 Number of Investors
East Coast Companies With Less Than $500M in Revenue (Top 10K)
9,945 Number of Organizations • $771.2B Total Funding Amount • 63,235 Number of Investors
Manufacturing Public Companies With Less Than $1B in Revenue
5,212 Number of Organizations • $136.5B Total Funding Amount • 2,434 Number of Investors
Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?

Frequently Asked Questions

Where is Repligen's headquarters? Repligen is located in Waltham, Massachusetts, United States.How much funding has Repligen raised to date? Repligen has raised .When was the last funding round for Repligen? Repligen closed its last funding round on Dec 6, 2023 from a Post-IPO Debt round.Who are Repligen's competitors? Alternatives and possible competitors to Repligen may include Gilead SciencesTakeda, and Synergy Pharmaceuticals.